Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-506' Or cancer = '' Total: 27 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-506 breast cancer down Up-regulation of miR-506 inhibits cell growth and disrupt the cell cycle by targeting YAP in breast cancer cells.
hsa-mir-506 cervical cancer down Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
hsa-mir-506 cervical cancer down miR-506 suppresses cervical cancer cell proliferation both in vitro and in vivo.
hsa-mir-506 colon cancer down MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
hsa-mir-506 colon cancer up Expression levels of miR-205 and miR-506 in colon cancer tissues and their relationships with clinicopathological features.
hsa-mir-506 colorectal cancer down miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1.
hsa-mir-506 colorectal cancer down miR-506 inhibits cell proliferation and invasion by targeting TET family in colorectal cancer.
hsa-mir-506 esophageal cancer down MicroRNA-506 inhibits esophageal cancer cell proliferation via targeting CREB1.
hsa-mir-506 gastric cancer down MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1.
hsa-mir-506 gastric cancer down miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer.
hsa-mir-506 glioblastoma down miR-506 inhibits the proliferation and invasion by targeting IGF2BP1 in glioblastoma.
hsa-mir-506 glioma down miR-506 functions as a tumor suppressor in glioma by targeting STAT3.
hsa-mir-506 hepatocellular carcinoma down MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR.
hsa-mir-506 hepatocellular carcinoma down microRNA-506 regulates proliferation, migration and invasion in hepatocellular carcinoma by targeting F-spondin 1 (SPON1).
hsa-mir-506 hepatocellular carcinoma down MiR-506 suppresses cell proliferation and tumor growth by targeting Rho-associated protein kinase 1 in hepatocellular carcinoma.
hsa-mir-506 liver cancer down MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA.
hsa-mir-506 lung cancer down Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro.
hsa-mir-506 nasopharyngeal carcinoma down MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma.
hsa-mir-506 neuroblastoma down miR-506 suppresses neuroblastoma metastasis by targeting ROCK1.
hsa-mir-506 oral squamous cell carcinoma down MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6.
hsa-mir-506 osteosarcoma down Overexpression of miR-506 suppresses proliferation and promotes apoptosis of osteosarcoma cells by targeting astrocyte elevated gene-1.
hsa-mir-506 pancreatic cancer down Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-?B signaling.
hsa-mir-506 pancreatic ductal adenocarcinoma up MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression.
hsa-mir-506 renal clear cell carcinoma down MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1.
hsa-mir-506 renal clear cell carcinoma down Correction: MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1.
hsa-mir-506-3p osteosarcoma down MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression.
hsa-mir-506-3p retinoblastoma down MiR-506-3p inhibits cell proliferation, induces cell cycle arrest and apoptosis in retinoblastoma by directly targeting NEK6.